ALB and neoplasm: Furthermore, CUHN013 tumor growth analysis showed a significant reduction in tumor volume by approximately 4 fold following sEphB4-HSA treatment + XRT compared to PBS+XRT on day 38 post-treatment (Fig. 4B, p < 0.005).